Hironao Takasawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hironao Takasawa has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Makoto Hayashi
Biosafety Research Center, Foods, Drugs, and Pesticides, 582-2, Shioshinden, Iwata, Shizuoka 437-1213, Japan
3 shared publicationsMasayoshi Kawabata
LSI Medience Corporation (Old name: Mitsubishi Chemical Medience Corporation), 14-1 Sunayama, Kamisu-shi, Ibaraki 314-0255, Japan
3 shared publicationsAkiko Hattori
LSI Medience Corporation (Old name: Mitsubishi Chemical Medience Corporation), 14-1 Sunayama, Kamisu-shi, Ibaraki 314-0255, Japan
2 shared publicationsAtsushi Miyazaki
Ina Research Inc., 2148-188 Nishiminowa, Ina-shi, Nagano 399-4501, Japan
2 shared publicationsHiroshi Suzuki
Ina Research Inc., 2148-188 Nishiminowa, Ina-shi, Nagano 399-4501, Japan
2 shared publicationsHirotaka Matsumoto
Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa 257-8523, Japan
2 shared publications
Latest Publications
- Open Access
- 19 October 2022
- Published by Springer Nature in Genes and Environment
- Vol. 44 (1) , 1-7
In vivo genotoxicity assessment of a multiwalled carbon nanotube in a mouse ex vivo culture
Background: Multiwalled carbon nanotubes (MWCNTs) are suspected lung carcinogens because their shape and size are similar to asbestos. Various MWCNT types are manufactured; however, only MWNT-7 is classified into Group 2B by The International Agency for Research on Cancer. MWNT-7’s carcinogenicity is strongly related to inflammatory reactions. On the other hand, inconsistent results on MWNT-7 genotoxicity have been reported. We previously observed no significant differences in bothPig-a(blood) andgpt(lung) mutant frequencies between MWNT-7-intratracheally treated and negative control rats. In this study, to investigatein vivoMWNT-7 genotoxicity on various endpoints, we attempted to develop a lung micronucleus assay throughex vivoculture targeting the cellular fraction of Clara cells and alveolar Type II (AT-II) cells, known as the initiating cells of lung cancer. Using this system, we analyzed thein vivoMWNT-7 genotoxicity induced by both whole-body inhalation exposure and intratracheal instillation. We also conducted an erythrocyte micronucleus assay using the samples obtained from animals under intratracheal instillation to investigate the tissue specificity of MWNT-7 induced genotoxicities.Results: We detected a significant increase in the incidence of micronucleated cells derived from the cellular fraction of Clara cells and AT-II cells in both MWNT-7-treated and positive control groups compared to the negative control group under both whole-body inhalation exposures and intratracheal instillation. Additionally, the erythrocyte micronucleus assay detected a significant increase in the incidence of micronucleated reticulocytes only in the positive control group.Conclusions: Our findings indicated that MWNT-7 was genotoxic in the lungs directly exposed by both the body inhalation and intratracheal instillation but not in the hematopoietic tissue.
- 19 October 2022
- Published by Springer Nature in Genes and Environment
- Vol. 44 (1) , 1-7
Open AccessIn vivo genotoxicity assessment of a multiwalled carbon nanotube in a mouse ex vivo culture
Background: Multiwalled carbon nanotubes (MWCNTs) are suspected lung carcinogens because their shape and size are similar to asbestos. Various MWCNT types are manufactured; however, only MWNT-7 is classified into Group 2B by The International Agency for Research on Cancer. MWNT-7’s carcinogenicity is strongly related to inflammatory reactions. On the other hand, inconsistent results on MWNT-7 genotoxicity have been reported. We previously observed no significant differences in bothPig-a(blood) andgpt(lung) mutant frequencies between MWNT-7-intratracheally treated and negative control rats. In this study, to investigatein vivoMWNT-7 genotoxicity on various endpoints, we attempted to develop a lung micronucleus assay throughex vivoculture targeting the cellular fraction of Clara cells and alveolar Type II (AT-II) cells, known as the initiating cells of lung cancer. Using this system, we analyzed thein vivoMWNT-7 genotoxicity induced by both whole-body inhalation exposure and intratracheal instillation. We also conducted an erythrocyte micronucleus assay using the samples obtained from animals under intratracheal instillation to investigate the tissue specificity of MWNT-7 induced genotoxicities.Results: We detected a significant increase in the incidence of micronucleated cells derived from the cellular fraction of Clara cells and AT-II cells in both MWNT-7-treated and positive control groups compared to the negative control group under both whole-body inhalation exposures and intratracheal instillation. Additionally, the erythrocyte micronucleus assay detected a significant increase in the incidence of micronucleated reticulocytes only in the positive control group.Conclusions: Our findings indicated that MWNT-7 was genotoxic in the lungs directly exposed by both the body inhalation and intratracheal instillation but not in the hematopoietic tissue.
- 1 November 2016
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 811, 75-79
Results of rat Pig-a/PIGRET assay with a single dose regimen of 1,3-propane sultone and 2-acetyl aminofluorene
- 1 November 2016
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 811, 75-79
Results of rat Pig-a/PIGRET assay with a single dose regimen of 1,3-propane sultone and 2-acetyl aminofluorene
- 1 July 2015
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 786-788, 144-150
Results of the International Validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: Individual data for 1,2-dibromoethane, p-anisidine, and o-anthranilic acid in the 2nd step of the 4th phase Validation Study under the JaCVAM initiative
- 1 July 2015
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 786-788, 144-150
Results of the International Validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: Individual data for 1,2-dibromoethane, p-anisidine, and o-anthranilic acid in the 2nd step of the 4th phase Validation Study under the JaCVAM initiative
- 30 April 2010
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 698 (1-2) , 24-29
Evaluation of a liver micronucleus assay in young rats (IV): A study using a double-dosing/single-sampling method by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)–Mammalian Mutagenicity Study Group (MMS)
- 30 April 2010
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 698 (1-2) , 24-29
Evaluation of a liver micronucleus assay in young rats (IV): A study using a double-dosing/single-sampling method by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)–Mammalian Mutagenicity Study Group (MMS)
- 25 February 2010
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 698 (1-2) , 30-37
Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)–Mammalian Mutagenicity Study Group (MMS)
- 25 February 2010
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 698 (1-2) , 30-37
Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)–Mammalian Mutagenicity Study Group (MMS)